DE602004025676D1 - Verfahren zur untersuchung einer zelle - Google Patents

Verfahren zur untersuchung einer zelle

Info

Publication number
DE602004025676D1
DE602004025676D1 DE602004025676T DE602004025676T DE602004025676D1 DE 602004025676 D1 DE602004025676 D1 DE 602004025676D1 DE 602004025676 T DE602004025676 T DE 602004025676T DE 602004025676 T DE602004025676 T DE 602004025676T DE 602004025676 D1 DE602004025676 D1 DE 602004025676D1
Authority
DE
Germany
Prior art keywords
cancer
cell
enabled
tissue
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004025676T
Other languages
English (en)
Inventor
Toshiyuki Sakai
Hideki Ishihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex Corp
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Publication of DE602004025676D1 publication Critical patent/DE602004025676D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004025676T 2003-02-26 2004-02-25 Verfahren zur untersuchung einer zelle Expired - Lifetime DE602004025676D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003048653 2003-02-26
PCT/JP2004/002164 WO2004076686A1 (ja) 2003-02-26 2004-02-25 細胞の検査方法

Publications (1)

Publication Number Publication Date
DE602004025676D1 true DE602004025676D1 (de) 2010-04-08

Family

ID=32923298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004025676T Expired - Lifetime DE602004025676D1 (de) 2003-02-26 2004-02-25 Verfahren zur untersuchung einer zelle

Country Status (6)

Country Link
US (1) US7501257B2 (de)
EP (1) EP1600513B1 (de)
JP (1) JP4317188B2 (de)
AT (1) ATE458830T1 (de)
DE (1) DE602004025676D1 (de)
WO (1) WO2004076686A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1767647B1 (de) * 2004-05-31 2010-11-24 Sysmex Corporation Verfahren zur beurteilung der malignität einer säuger-krebszelle
US7957910B2 (en) 2005-01-31 2011-06-07 Sysmex Corporation Method for predicting effectiveness of chemotherapy
JP4944446B2 (ja) * 2005-01-31 2012-05-30 シスメックス株式会社 抗がん剤治療の有効性予測方法
US7682785B2 (en) 2005-06-30 2010-03-23 Sysmex Corporation Method for predicting effectiveness of chemotherapy using anticancer agent
JP5046574B2 (ja) * 2005-06-30 2012-10-10 シスメックス株式会社 抗がん剤治療の有効性予測方法
EP1750131B1 (de) * 2005-08-01 2008-07-09 Sysmex Corporation Verfahren zur Beurteilung der Beschaffenheit maligner Tumore
JP4766969B2 (ja) * 2005-09-14 2011-09-07 シスメックス株式会社 組織性質判定装置
JP2007259846A (ja) 2006-02-28 2007-10-11 Sysmex Corp 悪性腫瘍の性質の判定方法
JP5408839B2 (ja) * 2006-10-20 2014-02-05 オリンパス株式会社 細胞周期解析方法
JP5111902B2 (ja) * 2007-03-14 2013-01-09 シスメックス株式会社 癌の診断支援装置
JP2009089672A (ja) * 2007-10-10 2009-04-30 Sysmex Corp がんの再発リスクの判定方法
JP2010057486A (ja) * 2008-09-02 2010-03-18 Sysmex Corp 化学療法に対するがん患者の応答の予測方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004316A1 (en) 1995-07-20 1997-02-06 Paracelsian, Inc. Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases
US5672508A (en) * 1996-01-23 1997-09-30 Mitotix, Inc. Inhibitors of cell-cycle progression, and uses related thereto
US6048693A (en) * 1996-10-16 2000-04-11 Bittech, Inc. Phenotypic assays of cyclin/cyclin-dependent kinase function
US5914249A (en) * 1997-12-05 1999-06-22 Incyte Pharmaceuticals, Inc. Cell-cycle phosphoproteins
ATE238555T1 (de) * 1998-02-18 2003-05-15 Theryte Ltd Krebsbehandlung
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US20030064426A1 (en) * 2001-02-01 2003-04-03 Jason Poole Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
EP1609854B1 (de) * 2001-02-14 2008-04-30 Sysmex Corporation Verfahren zur Bestimmung der Aktivität des Zellzyklus-Regulationsfaktors und Verfahren zur Diagnose von Krebs unter Verwendung desselben
JP4036655B2 (ja) * 2001-02-14 2008-01-23 シスメックス株式会社 細胞周期調節因子の活性の測定法と該測定法に使用される試薬
US20040126784A1 (en) * 2002-07-12 2004-07-01 Rigel Pharmaceuticals, Incorporated Modulators of cellular proliferation

Also Published As

Publication number Publication date
EP1600513B1 (de) 2010-02-24
US20070031813A1 (en) 2007-02-08
EP1600513A1 (de) 2005-11-30
ATE458830T1 (de) 2010-03-15
WO2004076686A1 (ja) 2004-09-10
JP4317188B2 (ja) 2009-08-19
US7501257B2 (en) 2009-03-10
EP1600513A4 (de) 2007-09-12
JPWO2004076686A1 (ja) 2006-06-08

Similar Documents

Publication Publication Date Title
DE602004025676D1 (de) Verfahren zur untersuchung einer zelle
DE60135496D1 (de) Verbessertes verfahren und verbesserte vorrichtung zur erfassung und diagnose von krankheiten unter verwendung von elektrischer impedanz
WO2015071876A3 (en) Use of microrna markers for diagnosis of thyroid tumors and a diagnostic panel containing such markers.
AU2012246764B2 (en) A Device and Method for Detecting a Harmonic Response Characteristic of Secondary Dental Caries Diagnosis
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
WO2008015599A3 (en) A method of in vivio detection and/or diagnosis of cancer using fluorescence based dna image cytometry
ATE412950T1 (de) Quantifizierug auf basis virtueller läsionen
ATE538809T1 (de) Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff
EP1215495A3 (de) Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
WO2006110768A3 (en) System, method and software arrangement for analyzing and correlating molecular profiles associated with anatomical structures
KR20180131092A (ko) 암 진단 및 수술용 형광 영상 시스템의 3차원 형광 영상 획득 장치 및 방법
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
US20220107319A1 (en) Systems and methods for the molecular quantification of skin damage in skin
Wheller et al. Noninvasive methods for the assessment of photoageing
KR101207750B1 (ko) 생체분해성 마그네슘합금의 부식평가킷 및 이를 이용한 생체분해성 마그네슘합금의 부식평가방법
Hemphill Tooth size apportionment among contemporary Indians: An analysis of caste, language, and geography.
RU2013103779A (ru) Индекс гигиены полости рта
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
CN103040478A (zh) 标准化检测双能量x光骨质密度吸收测量仪器品质的方法
Moghaddam et al. In vitro detection of simulated apical root perforation with two electronic apex locators
Sabour et al. Accuracy of peri-implant bone thickness and validity of assessing bone augmentation material using cone beam computed tomography—is this correct?
ATE466285T1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
de Boer Detecting breast cancer tissue with diffuse reflectance spectroscopy
Jordán-López et al. Validation of substances used for calibrating the Periotron 8000 instrument and conversion equations: An invitro study

Legal Events

Date Code Title Description
8364 No opposition during term of opposition